Employment Verification
for Allogene Therapeutics.
Fast, secure, and automated employment verification for Allogene Therapeutics employees.
$39.99 per verification
Pay only when it worksAbout Allogene Therapeutics
Allogene Therapeutics is a clinical-stage biotechnology company that develops next-generation, off-the-shelf CAR T cell therapies for cancer treatment. The company was founded in April 2018 by Arie Belldegrun and David Chang, two pioneers in the field of cell therapy. Allogene Therapeutics leverages cutting-edge technologies to develop allogeneic CAR T cell therapies, which means that the T cells come from a healthy donor rather than the patient receiving the therapy. This approach allows for a more efficient and scalable manufacturing process, as well as a consistent and quality-controlled product. The company’s lead product candidate, ALLO-501, targets CD19-positive malignancies, including B-cell lymphomas and leukemias. In September 2020, the company announced positive interim data from its Phase 1 clinical trial of ALLO-501, showing promising safety and efficacy results. Allogene Therapeutics has also developed a proprietary gene editing platform, AlloCAR, which enables precise modification of allogeneic CAR T cells to enhance their potency and duration of activity in the body. The company is headquartered in South San Francisco, California, with additional operations in Newark, California, and New York City. Allogene Therapeutics is backed by several high-profile investors, including Takeda Pharmaceutical Company Limited, Pfizer Inc., and Fidelity Management & Research Company, among others.
The information on this page is not an endorsement of Truv’s services by Allogene Therapeutics and is meant to be purely informational.
Verify Allogene Therapeutics Employees
- Fast and automated verification: Most employment and income verifications are completed in under 24 hours.
- Secure and reliable: Truv is SOC2 TYPEII Compliant. Certified for Fannie Mae’s Day 1 Certainty® and Freddie Mac’s AIM®.
- Cost-effective pricing: Pay only for successful verifications and save up to 50% compared to competitors.
Category
BiotechnologyNumber of employees
200.0 – 500.0
Information sourced from public company data.
Allogene Therapeutics Employment Verification FAQs.
You can verify employment for Allogene Therapeutics employees through Truv, a secure and automated verification service. Truv provides quick and cost-effective employment verifications for Allogene Therapeutics and many other employers.
Yes, Truv offers both employment and income verification services for Allogene Therapeutics employees. This service is designed to be comprehensive, covering both employment status and income information.
Most verifications through Truv are completed in under 24 hours.
Yes, we emphasize security in our verification process. Truv provides secure and automated verifications to protect employee information.
Truv operates on a pay-per-success model, meaning you only pay for successful verifications. On average, users save about 50% compared to competitors’ services.
Yes, Truv provides verification services for various Biotechnology companies. Some examples mentioned include BioAgilytix, Akoya Biosciences and ICM.
No, the information provided about Truv’s verification services is not an endorsement by the Allogene Therapeutics.
Not the employer you were looking for?
Also verified with Truv
About Allogene Therapeutics
Allogene Therapeutics is a clinical-stage biotechnology company that develops next-generation, off-the-shelf CAR T cell therapies for cancer treatment. The company was founded in April 2018 by Arie Belldegrun and David Chang, two pioneers in the field of cell therapy. Allogene Therapeutics leverages cutting-edge technologies to develop allogeneic CAR T cell therapies, which means that the T cells come from a healthy donor rather than the patient receiving the therapy. This approach allows for a more efficient and scalable manufacturing process, as well as a consistent and quality-controlled product. The company’s lead product candidate, ALLO-501, targets CD19-positive malignancies, including B-cell lymphomas and leukemias. In September 2020, the company announced positive interim data from its Phase 1 clinical trial of ALLO-501, showing promising safety and efficacy results. Allogene Therapeutics has also developed a proprietary gene editing platform, AlloCAR, which enables precise modification of allogeneic CAR T cells to enhance their potency and duration of activity in the body. The company is headquartered in South San Francisco, California, with additional operations in Newark, California, and New York City. Allogene Therapeutics is backed by several high-profile investors, including Takeda Pharmaceutical Company Limited, Pfizer Inc., and Fidelity Management & Research Company, among others.
The information on this page is not an endorsement of Truv’s services by Allogene Therapeutics and is meant to be purely informational.
Verify Allogene Therapeutics Employees
Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee. Learn more
Category
BiotechnologyNumber of employees
200.0 – 500.0
Allogene Therapeutics Employment Verification FAQ.
You can verify employment for Allogene Therapeutics employees through Truv, a secure and automated verification service. Truv provides quick and cost-effective employment verifications for Allogene Therapeutics and many other employers.
Yes, Truv offers both employment and income verification services for Allogene Therapeutics employees. This service is designed to be comprehensive, covering both employment status and income information.
Most verifications through Truv are completed in under 24 hours.
Yes, we emphasizes security in our verification process. Truv provides secure and automated verifications to protect employee information.
Truv operates on a pay-per-success model, meaning you only pay for successful verifications. On average, users save about 50% compared to competitors’ services.
Yes, Truv provides verification services for various Biotechnology companies. Some examples mentioned include BioAgilytix, Akoya Biosciences and ICM.
No, the information provided about Truv’s verification services is not an endorsement by the Allogene Therapeutics.
Yes, Truv provides an option to « Start a verification » directly from this website for Allogene Therapeutics employees and employees of many other organizations.